Cargando…
Modeling the impact of drug interactions on therapeutic selectivity
Combination therapies that produce synergistic growth inhibition are widely sought after for the pharmacotherapy of many pathological conditions. Therapeutic selectivity, however, depends on the difference between potency on disease-causing cells and potency on non-target cell types that cause toxic...
Autores principales: | Weinstein, Zohar B., Kuru, Nurdan, Kiriakov, Szilvia, Palmer, Adam C., Khalil, Ahmad S., Clemons, Paul A., Zaman, Muhammad H., Roth, Frederick P., Cokol, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110842/ https://www.ncbi.nlm.nih.gov/pubmed/30150706 http://dx.doi.org/10.1038/s41467-018-05954-3 |
Ejemplares similares
-
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
por: Cokol, Murat, et al.
Publicado: (2017) -
A Toolkit for Precise, Multigene Control in Saccharomyces cerevisiae
por: Sanford, Adam, et al.
Publicado: (2022) -
Target-Independent
Prediction of Drug Synergies Using
Only Drug Lipophilicity
por: Yilancioglu, Kaan, et al.
Publicado: (2014) -
Guided screen for synergistic three-drug combinations
por: Cokol-Cakmak, Melike, et al.
Publicado: (2020) -
Protein assembly systems in natural and synthetic biology
por: Chiesa, Giulio, et al.
Publicado: (2020)